These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 28591114)

  • 1. First deuterated drug approved.
    Schmidt C
    Nat Biotechnol; 2017 Jun; 35(6):493-494. PubMed ID: 28591114
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals.
    Russak EM; Bednarczyk EM
    Ann Pharmacother; 2019 Feb; 53(2):211-216. PubMed ID: 30136594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deuterated Drug Molecules: Focus on FDA-Approved Deutetrabenazine
    DeWitt SH; Maryanoff BE
    Biochemistry; 2018 Feb; 57(5):472-473. PubMed ID: 29160059
    [No Abstract]   [Full Text] [Related]  

  • 4. Tetrabenazine.
    Hayden MR; Leavitt BR; Yasothan U; Kirkpatrick P
    Nat Rev Drug Discov; 2009 Jan; 8(1):17-8. PubMed ID: 19116624
    [No Abstract]   [Full Text] [Related]  

  • 5. Deutetrabenazine: Treatment of hyperkinetic aspects of Huntington's disease, tardive dyskinesia and Tourette syndrome.
    Paton DM
    Drugs Today (Barc); 2017 Feb; 53(2):89-102. PubMed ID: 28387387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of deutetrabenazine: a novel treatment for chorea associated with Huntington's disease.
    Dean M; Sung VW
    Drug Des Devel Ther; 2018; 12():313-319. PubMed ID: 29497277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deutetrabenazine-Not a Revolution but Welcome Evolution for Treating Chorea in Huntington Disease.
    Reilmann R
    JAMA Neurol; 2016 Dec; 73(12):1404-1406. PubMed ID: 27749952
    [No Abstract]   [Full Text] [Related]  

  • 8. Two New Drugs for Tardive Dyskinesia Hit the Market.
    Morrow T
    Manag Care; 2018 Jan; 27(1):35-36. PubMed ID: 29369770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valbenazine: First Global Approval.
    Kim ES
    Drugs; 2017 Jul; 77(10):1123-1129. PubMed ID: 28578484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient Trial Design - FDA Approval of Valbenazine for Tardive Dyskinesia.
    Davis MC; Miller BJ; Kalsi JK; Birkner T; Mathis MV
    N Engl J Med; 2017 Jun; 376(26):2503-2506. PubMed ID: 28489481
    [No Abstract]   [Full Text] [Related]  

  • 11. [Tetrabenazine (tetrabenazine Orphan) orally].
    J Pharm Belg; 2014 Dec; (4):49-50. PubMed ID: 25562927
    [No Abstract]   [Full Text] [Related]  

  • 12. Valbenazine granted breakthrough drug status for treating tardive dyskinesia.
    Müller T
    Expert Opin Investig Drugs; 2015 Jun; 24(6):737-42. PubMed ID: 25809133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Letter: Tetrabenazine in chorea.
    Astin KJ; Gumpert EW
    Lancet; 1974 Mar; 1(7856):512. PubMed ID: 4131918
    [No Abstract]   [Full Text] [Related]  

  • 14. Deutetrabenazine: A Review in Chorea Associated with Huntington's Disease.
    Heo YA; Scott LJ
    Drugs; 2017 Nov; 77(17):1857-1864. PubMed ID: 29080203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Updates on the Development of Deuterium-Containing Drugs for the Treatment of Cancer.
    Belete TM
    Drug Des Devel Ther; 2022; 16():3465-3472. PubMed ID: 36217450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Huntington’s Disease Clinical Trials Corner: February 2018.
    Rodrigues FB; Wild EJ
    J Huntingtons Dis; 2018; 7(1):89-98. PubMed ID: 29480210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VMAT2 Inhibitors: New Drugs for the Treatment of Tardive Dyskinesia.
    Kim AP; Baker DE; Levien TL
    Consult Pharm; 2018 Apr; 33(4):201-209. PubMed ID: 29609698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetrabenazine in the treatment of hyperkinetic movement disorders.
    Kenney C; Jankovic J
    Expert Rev Neurother; 2006 Jan; 6(1):7-17. PubMed ID: 16466307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deuterated drugs; updates and obviousness analysis.
    Timmins GS
    Expert Opin Ther Pat; 2017 Dec; 27(12):1353-1361. PubMed ID: 28885861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tetrabenazine for Huntington's chorea.
    Soutar CA
    Br Med J; 1970 Oct; 4(5726):55. PubMed ID: 4248502
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.